Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06EXI
|
|||
| Former ID |
DIB013363
|
|||
| Drug Name |
FGLL
|
|||
| Synonyms |
NCAM mimetics (Alzheimer's disease), Enkam
Click to Show/Hide
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [1] | |
| Company |
ENKAM Pharmaceuticals A/S
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Neural cell adhesion molecule (NCAM) | Target Info | Modulator | [1] |
| KEGG Pathway | Cell adhesion molecules (CAMs) | |||
| Prion diseases | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An NCAM mimetic, FGL, alters hippocampal cellular morphometry in young adult (4 month-old) rats. Neurochem Res. 2013 Jun;38(6):1208-18. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.